These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25238512)

  • 1. Strengthening bone in neurofibromatosis type 1.
    Harrington M
    Lab Anim (NY); 2014 Oct; 43(10):338. PubMed ID: 25238512
    [No Abstract]   [Full Text] [Related]  

  • 2. Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
    de la Croix Ndong J; Makowski AJ; Uppuganti S; Vignaux G; Ono K; Perrien DS; Joubert S; Baglio SR; Granchi D; Stevenson DA; Rios JJ; Nyman JS; Elefteriou F
    Nat Med; 2014 Aug; 20(8):904-10. PubMed ID: 24997609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
    Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
    J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurofibromin and melatonin in pathogenesis of pseudarthrosis after spinal fusion for neurofibromatous scoliosis.
    Abdel-Wanis ME; Kawahara N
    Med Hypotheses; 2002 May; 58(5):395-8. PubMed ID: 12056876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1).
    Schindeler A; Little DG
    Bone; 2008 Apr; 42(4):616-22. PubMed ID: 18248783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 (NF1): diagnosis and management.
    Ferner RE; Gutmann DH
    Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model for learning and memory defects associated with neurofibromatosis type I.
    Silva AJ; Elgersma Y; Friedman E; Stern J; Kogan J
    Pathol Biol (Paris); 1998 Nov; 46(9):697-8. PubMed ID: 9885821
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple roles for neurofibromin in skeletal development and growth.
    Kolanczyk M; Kossler N; Kühnisch J; Lavitas L; Stricker S; Wilkening U; Manjubala I; Fratzl P; Spörle R; Herrmann BG; Parada LF; Kornak U; Mundlos S
    Hum Mol Genet; 2007 Apr; 16(8):874-86. PubMed ID: 17317783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
    Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
    Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis.
    McClatchey AI
    Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1.
    Liu N; Xu N; Wei LH; Chai GL
    Chin Med J (Engl); 2013 Jan; 126(1):101-7. PubMed ID: 23286486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromin: a general outlook.
    Trovó-Marqui AB; Tajara EH
    Clin Genet; 2006 Jul; 70(1):1-13. PubMed ID: 16813595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ethamoxytriphetol on the fetal bone development in the rabbit.
    Abdul-Karim RW; Shelley TF; Marshall LD; Rizk PT
    J Reprod Med; 1970 Apr; 4(4):59-62. PubMed ID: 5535320
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasculopathy in two cases of NF1-related congenital pseudarthrosis.
    Kuorilehto T; Kinnunen P; Nissinen M; Alanne M; Leskelä HV; Lehenkari P; Peltonen J
    Pathol Res Pract; 2006; 202(9):687-90. PubMed ID: 16735097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of spinal deformities in neurofibromatosis 1: new hypotheses.
    Abdel-Wanis ME; Kawahara N
    Med Hypotheses; 2001 Mar; 56(3):400-4. PubMed ID: 11359370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis.
    Kuorilehto T; Ekholm E; Nissinen M; Hietaniemi K; Hiltunen A; Paavolainen P; Penttinen R; Peltonen J
    J Histochem Cytochem; 2006 Mar; 54(3):363-70. PubMed ID: 16314442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromin, a tumor suppressor in the nervous system.
    Zhu Y; Parada LF
    Exp Cell Res; 2001 Mar; 264(1):19-28. PubMed ID: 11237520
    [No Abstract]   [Full Text] [Related]  

  • 19. Motor deficits and neurofibromatosis type 1 (NF1)-associated MRI impairments in a mouse model of NF1.
    Robinson A; Kloog Y; Stein R; Assaf Y
    NMR Biomed; 2010 Dec; 23(10):1173-80. PubMed ID: 20586111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.